Search Results - Steven Knapper

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    The FLAM regimen: revisiting time sequential induction therapy for patients with poor-risk acute myeloid leukemia by Steven Knapper

    Published in Haematologica (2015-09-01)
    Get full text
    Article


  2. 2

    The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine by Elisabeth J. Walsby, Steven J. Coles, Steven Knapper, Alan K. Burnett

    Published in Haematologica (2011-03-01)
    Get full text
    Article


  3. 3

    S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM... by Steven Knapper, Abin Thomas, Sophie King, Ian Thomas, Amanda Gilkes, Sarah Irwin, Robert Sellar, Simone Green, Ulrik Malthe Overgaard, Priyanka Mehta, Mike Dennis, Sylvie Freeman, Nigel Russell

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  4. 4

    P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT... by Nigel Russell, Oliver Cumming, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Jelena Jovanovic, Amanda Gilkes, Leona Batten, Joanna Canham, Emily Laura Hinson, Panagiotis Kottaridis, Jamie Cavenagh, Claire Arnold, Mike Dennis, Steven Knapper

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  5. 5

    P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIP... by Emma Searle, Jim Cavet, Steven Knapper, Ceri Bygrave, Victoria Campbell, Dima El-Sharkawi, Charlotte Pawlyn, Maria Creignou, Harriet S. Walter, David Valcarcel, Marta Hidalgo, Tomasz Knurowski, Karen Clegg, Neil Pegg, Will West, Debbie Haynes, Kris Frese, Tim C. P. Somervaille

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  6. 6

    S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 T... by Nigel Russell, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Steven Knapper, Leona Batten, Joanna Canham, Emily Laura Hinson, Ulrik Malthe Overgaard, Amanda Gilkes, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie Freeman, Mike Dennis

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  7. 7

    S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY by Francesco Passamonti, Andrea Patriarca, Steven Knapper, Candido Rivera, Joseph M Scandura, Timothy Devos, Nikki Granacher, Adam Mead, Stephen Oh, Jeanne Palmer, Raajit K Rampal, Lino Teichmann, Qing LI, Jean-Pierre Eliane, Tzuu-Wang Chang, Sandra Klein, Gozde Colak, Claire Harrison

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  8. 8

    Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia by Paul Milne, Charlotte Wilhelm-Benartzi, Michael R. Grunwald, Venetia Bigley, Richard Dillon, Sylvie D. Freeman, Kathleen Gallagher, Amy Publicover, Sarah Pagan, Helen Marr, Gail L. Jones, Anne M. Dickinson, Angela Grech, Alan K. Burnett, Nigel H. Russell, Mark Levis, Steven Knapper, Matthew Collin

    Published in Blood Advances (2019-10-01)
    Get full text
    Article


  9. 9

    P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STANDARD CLINICAL CARE IN YOUNGER ADULTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 AND AML19 STUDIES by Nicola Potter, Jelena Jovanovic, Adam Ivey, Abin Thomas, Charlotte Wilhelm-Benartzi, Amanda Gilkes, Ian Thomas, Sean Johnson, Joanna Canham, Steven Knapper, Asim Khwaja, Mary Frances Mcmullin, Jamie Cavenagh, Ulrik Malthe Overgaard, Richard Clark, Ellen Solomon, Sylvie Freeman, Robert Hills, Alan Burnett, Nigel Russell, Richard Dillon

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  10. 10

    Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a m... by Ernest Choy, Kerenza Hood, Emma Thomas-Jones, Eleanor Barnes, Keith Wilson, Christian H Ottensmeier, Debbie Harris, Adrian Hill, Mark Tuthill, Richard Adams, Catherine Porter, Katie Ewer, Sian Griffin, Rebecca Tangney, Joanne Euden, Shirley Pringle, Lawrence Raisanen, Ruby Ray, Lisette Sheena Nixon, Melanie Varley, Craig Bodman, Paola Cicconi, Vivien Dagley, Steven Knapper

    Published in BMJ Open (2025-01-01)
    Get full text
    Article


  11. 11

    Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis by Zijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell, Rebecca H. Boucher, Aimee Jackson, Rachel S. Fletcher, Dorian Forte, Jose-Ezequiel Martin, Sonia Fox, James Roberts, Rachel Glover, Erica Harris, Hannah R. Bridges, Luigi Grassi, Alba Rodriguez-Meira, Adam J. Mead, Steven Knapper, Joanne Ewing, Nauman M. Butt, Manish Jain, Sebastian Francis, Fiona J. Clark, Jason Coppell, Mary F. McMullin, Frances Wadelin, Srinivasan Narayanan, Dragana Milojkovic, Mark W. Drummond, Mallika Sekhar, Hesham ElDaly, Judy Hirst, Maike Paramor, E. Joanna Baxter, Anna L. Godfrey, Claire N. Harrison, Simón Méndez-Ferrer

    Published in Nature Communications (2023-11-01)
    Get full text
    Article


Search Tools: